Cargando…

Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country

OBJECTIVE: This study aimed to evaluate the seroprevalence of anti-SARS-CoV-2 IgG and factors associated with the infection among PLWHIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso. DESIGN: A retrospective cross-sectional study of plasma samples collected from March 9...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaboré, Odilon D., Poda, Armel, Ouattara, Cheick Ahmed, Michodigni, Fernand N., Belem, Abdoul-Aziz, Sawadogo, Yacouba, Zoungrana, Jacques, Galal, Lokman, Meda, Clément Z., Godreuil, Sylvain, Ouédraogo, Abdoul-Salam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266635/ https://www.ncbi.nlm.nih.gov/pubmed/37315090 http://dx.doi.org/10.1371/journal.pone.0286665

Ejemplares similares

Evaluation of the impact of COVID-19 in people coinfected with HIV and/or tuberculosis in low-income countries: study protocol for mixed methods research in Burkina Faso
por: Ouattara, Cheick Ahmed, et al.
Publicado: (2023)

Pregnancy rate and birth outcomes among women receiving antiretroviral therapy in Burkina Faso: a retrospective cohort study
por: Poda, Armel, et al.
Publicado: (2016)

Analytical performances of the Xpert MTB/RIF assay using stool specimens to improve the diagnosis of pulmonary tuberculosis in Burkina Faso, a tuberculosis endemic country
por: Kaboré, Odilon D., et al.
Publicado: (2023)

Long-term evolution of immunological and virological parameters in patients undergoing treatments for HIV-1 infection at the Day Hospital of Bobo-Dioulasso, Burkina Faso
por: Samba, Jessica Julie Chantal, et al.
Publicado: (2023)

Genomic Epidemiology of SARS-CoV-2 in Western Burkina Faso, West Africa
por: Sawadogo, Yacouba, et al.
Publicado: (2022)

Predictors of severe hypoxemia among COVID-19 patients in Burkina Faso (West Africa): Findings from hospital based cross-sectional study
por: Diendéré, Eric Arnaud, et al.
Publicado: (2021)

High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso
por: Ouedraogo, Abdoul-Salam, et al.
Publicado: (2016)

Dengue infection during pregnancy in Burkina Faso: a cross-sectional study
por: Sondo, Kongnimissom Apoline, et al.
Publicado: (2019)

Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

Multiparity and Breast Cancer Risk Factor among Women in Burkina Faso
por: Zouré, Abdou Azaque, et al.
Publicado: (2016)

High Nasal Carriage Rate of Staphylococcus aureus Containing Panton-Valentine leukocidin- and EDIN-Encoding Genes in Community and Hospital Settings in Burkina Faso
por: Ouedraogo, Abdoul-Salam, et al.
Publicado: (2016)

Task-Shifting Immunization Activities to Community Health Workers: A Mixed-Method Cross-Sectional Study in Sahel Region, Burkina Faso
por: Ouédraogo, Hamed Sidwaya, et al.
Publicado: (2023)

Incidence and Predictors of Imported Cases of COVID-19 in Burkina Faso
por: Kaboré, Mikaila, et al.
Publicado: (2022)

Identification of Streptococcus suis Meningitis by Direct Triplex Real-Time PCR, Burkina Faso
por: Ouattara, Mahamoudou, et al.
Publicado: (2020)

Severe dengue in adults and children, Ouagadougou (Burkina Faso), West Africa, October 2015–January 2017
por: Sondo, Apoline Kongnimissom, et al.
Publicado: (2021)

Serological profile of hepatitis B in children after the introduction of its vaccination in Burkina Faso
por: Barro, Makoura, et al.
Publicado: (2019)

Spatio-Temporal Determinants of Dengue Epidemics in the Central Region of Burkina Faso
por: Ouattara, Cheick Ahmed, et al.
Publicado: (2023)

Impact of Multiplex PCR in Reducing the Risk of Residual Transfusion-Transmitted Human Immunodeficiency and Hepatitis B and C Viruses in Burkina Faso
por: Yooda, Arzouma Paul, et al.
Publicado: (2018)

Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
por: Rouamba, Toussaint, et al.
Publicado: (2021)

Red blood cell alloimmunisation in multi-transfused patients from an haemodialysis service in Burkina Faso
por: Nebie, Koumpingnin, et al.
Publicado: (2022)

World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal
por: Diarra, Birama, et al.
Publicado: (2018)

Etat des lieux des mycobactérioses atypiques au Burkina Faso: résultats d'une enquête régionale
por: Zida, Sylvie, et al.
Publicado: (2014)

Knowledge, Attitudes, and Practices Related to Antibiotic Use and Antibiotic Resistance among Poultry Farmers in Urban and Peri-Urban Areas of Ouagadougou, Burkina Faso
por: Sawadogo, Abdallah, et al.
Publicado: (2023)

Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reactive vaccination
por: Soeters, Heidi M., et al.
Publicado: (2020)

Spatiotemporal analysis of dengue fever in Burkina Faso from 2016 to 2019
por: Ouattara, Cheick Ahmed, et al.
Publicado: (2022)

Climate factors and dengue fever in Burkina Faso from 2017 to 2019
por: Ouattara, Cheick Ahmed, et al.
Publicado: (2022)

Cytotoxicity of Particulate Matter PM(10) Samples from Ouagadougou, Burkina Faso
por: Guissou, Joelle Nicole, et al.
Publicado: (2022)

Impact of pre-analytical factors on mycobacterium cultures contaminations rates in Burkina Faso, West Africa
por: Kaboré, Antoinette, et al.
Publicado: (2014)

Immunovirological discordance among female sex workers who start antiretroviral therapy in Burkina Faso
por: Bazié, Wilfried Wenceslas, et al.
Publicado: (2022)

Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso
por: Yooda, Arzouma Paul, et al.
Publicado: (2019)

Seroprevalence, Genotyping, and Monitoring of Hepatitis C Viral Loads in Patients on Antivirals in Burkina Faso
por: Yelemkoure, Edwige T., et al.
Publicado: (2021)

Aflatoxins contents determination in some foodstuffs in Burkina Faso and human health risk assessment
por: Bandé, Moumouni, et al.
Publicado: (2022)

Characteristics of Obstetric and Iatrogenic Urogenital Fistulas in Burkina Faso: A Cross-Sectional Study
por: Kabore, Fasnéwindé Aristide, et al.
Publicado: (2021)

Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study)
por: Tall, Haoua, et al.
Publicado: (2021)

Description d’un nouveau foyer épidémique de leishmaniose cutanée à Leishmania major à l’Ouest du Burkina Faso
por: Konate, Issouf, et al.
Publicado: (2020)

Transfer of Bisphenol A and Trace Metals from Plastic Packaging to Mineral Water in Ouagadougou, Burkina Faso
por: Sawadogo, Boukary, et al.
Publicado: (2023)

Domestic donkey bite of genitalia: an unusual etiology of penile glans amputation in Burkina Faso (case report and literature review)
por: Ouattara, Adama, et al.
Publicado: (2020)

Assessment of Genetic Diversity of a Collection of Senna obtusifolia (L.) Irwin and Barneby Using SSRs Markers in Burkina Faso
por: Nacambo, Haoua, et al.
Publicado: (2023)

Rubella seroprevalence among pregnant women in Burkina Faso
por: Tahita, Marc C, et al.
Publicado: (2013)

Spatio-temporal dynamic of malaria in Ouagadougou, Burkina Faso, 2011–2015
por: Ouedraogo, Boukary, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b3omk2j5fo0avgvil6sf0d4ldd